BRAF mutation and age in differentiated thyroid cancer risk stratification: Two sides of the same coin.

Abstract excerpt

BRAF V600E mutation is seen in about 45% of patients with Papillary Thyroid Carcinoma (PTC). Thyroid cancers are among the unique cancers where the age influences the prognosis. Current evidence suggests BRAF mutation in the presence of other risk factors in DTC is associated with poor prognosis. Considering the high prevalence of the BRAF mutation in differentiated thyroid cancer, there has been an inclination...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Age Factors
• Share to Mutation
• Share to Prognosis